Advanced Micro Devices (AMD) finds itself navigating contrasting narratives as it pursues leadership in artificial intelligence while facing intensified examination of its financial performance. Recent developments highlight both the semiconductor giant’s ambitious growth initiatives and the mounting pressure on its profit margins.
Strategic Expansion into Specialized AI Markets
This week, AMD announced a significant collaboration with Oracle Cloud Infrastructure and biotechnology firm Absci to accelerate AI-powered drug discovery. The initiative centers on deploying AMD’s high-performance Instinct MI355X series GPUs and EPYC CPUs within Oracle’s cloud infrastructure to power Absci’s generative AI platform. This partnership aims to substantially reduce development cycles for biologics and bring new therapies to market faster.
The alliance represents a strategic move to position AMD’s AI hardware beyond conventional computing applications into highly specialized, high-growth sectors. This vision was reinforced by Senior Vice President Jack Huynh during his presentation at IFA 2025, where he characterized the current state of artificial intelligence as “underhyped”—suggesting the technology hasn’t yet reached its full valuation potential.
Mounting Profitability Concerns
Despite these forward-looking initiatives, financial analysts are expressing caution. Erste Group recently downgraded AMD shares from “Buy” to “Hold,” citing concerns about the company’s profitability metrics. Although AMD demonstrated robust revenue growth in its most recent quarter, it reported slightly negative EBIT margins.
Should investors sell immediately? Or is it worth buying AMD?
Market experts point to the substantial investments required to compete for market share in the demanding data center and AI sectors as a primary factor pressuring profitability. These concerns were further highlighted by recent management changes, including the September 5 departure of Chief Accounting Officer Philip Carter—a development that brought renewed attention to the company’s financial operations, despite being characterized as mutually agreed.
Critical Juncture for Investors
The coming quarters present a crucial test for AMD’s strategic direction. Market participants are watching for concrete progress in expanding Instinct accelerator sales and, more importantly, seeking clear evidence of a path toward improved operating margins. The company’s Q3 2025 results, scheduled for release in November, will serve as a significant milestone for assessing these developments.
While most analysts maintain a “Moderate Buy” rating and continue to support AMD’s long-term AI narrative, the recent downgrade signals a shifting market sentiment. Pure revenue growth no longer satisfies investor expectations—the market now demands tangible proof of improved profitability. AMD’s ability to demonstrate both technological leadership and financial discipline will ultimately determine its competitive position in the intensely contested AI and high-performance computing landscape.
Ad
AMD Stock: Buy or Sell?! New AMD Analysis from September 13 delivers the answer:
The latest AMD figures speak for themselves: Urgent action needed for AMD investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 13.
AMD: Buy or sell? Read more here...